The FDA has launched a safety investigation into Novartis’ gene therapy Zolgensma following reports of tumors in patients, as ...
Johnson & Johnson’s much-hyped Icotyde pill shows another biologic-like efficacy in inflammatory diseases, with a phase 3 win ...
Eli Lilly could soon see two label expansions for Foundayo, it’s oral GLP-1, in swift succession: In September, the drugmaker ...
Sticking by the strong relationship Moderna has fostered with the United Kingdom, the mRNA specialist is relocating its home base in the country to a different part of the capital. | Sticking by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results